Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06350968
Status:
RECRUITING
Last Update Posted:
2024-04-08
First Post:
2023-12-06
Brief Title:
Implementation of Online Advance Care Planning Tool for Hemato-Oncological Patients Within the Cancer Network Concord
Sponsor:
Erasmus Medical Center
Organization:
Erasmus Medical Center
Study Overview
Official Title:
Implementation of Online Advance Care Planning Tool for Hemato-Oncological Patients Within the Cancer Network Concord
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
INDEED
Brief Summary:
The aim of this mixed-methods study is to describe both the implementation process and outcomes of the online module Advance Care Plan for hemato-oncology patients within the oncology-network CONCORD
The main question is How is implementation and assurance of the advance care plan in daily care for hemato-oncological patients within CONCORD achieved so that early integration of advance care planning in oncological care takes place and patient preferences are discussed
Healthcare providers and patients are asked to use the module and share their experiences with it
The main question is How is implementation and assurance of the advance care plan in daily care for hemato-oncological patients within CONCORD achieved so that early integration of advance care planning in oncological care takes place and patient preferences are discussed
Healthcare providers and patients are asked to use the module and share their experiences with it
Detailed Description:
Design Implementation research with a mixed-method design Population
The implementation of advance care planning should benefit the care of hemato-oncology patients aged 18 years and older during the palliative phase of their illness The research focuses on
Oncology patients who have been treated in one or more hospitals from the oncology-network CONCORD after their death quantitative research
Oncology patients treated with palliative intent in one or more hospitals from this network interviews
Healthcare providers and implementation staff in the relevant hospitals and from the service area interviews Goal The aim of this project is to implement advance care planning in hemato-oncology patients treated in one of the hospitals within the oncology-network CONCORD so that personal preferences and treatment agreements lead to an appropriate treatment plan This is examined through the process of implementation and assurance of advance care planning in oncological care
MAIN QUESTION How is implementation and assurance of the online module advance care planning in daily care for hemato-oncological patients within the oncology-network CONCORD achieved so that early integration of advance care planning in oncological care takes place and patient preferences are discussed Method
Qualitative research
Description of the initial situation and the context within each institution but also of general practitioners and patients using the NASSS Framework Interviews with project leader project coordinators in each hospital healthcare providers from 1st 2nd and 3rd lines patients and relatives at the start and end of the project 3-5 in each target group per hospital taking into account the greatest possible degree of diversity in age gender and background At the end of the project the interviews are repeated to gather information about the experiences and lessons learned and the experiences with facilitating and hindering factors Each interview is transcribed and analyzed using NVivio or Atlasti analysis programs for qualitative data
Quantitative research
EHR-research based on anonymized data using a dashboard A dashboard is being built in each hospital to analyze data from hemato-oncological patients who have been treated in the relevant hospital and have died The dashboard contains demographic and medical data the use of the proactive care module and medical consumption in the last three months of their lives
In each of the participating hospitals the hemato-oncological patients who died in the last 3 months of 2022 2023 2024 and 2025 are selected and it will be examined to what extent the advance care plan has been completed and what kind of care the patients have received A Health economic analysis is carried out using the data from the dashboard On the one hand this involves the costs of implementing the advance care planning module used In addition the dashboard maps medical consumption in the last three months of life eg ICU admissions ER visits clinical admissions etc This is translated into the nationally determined costs for this This is done both before and after implementation has been mapped out among people who have died making it possible to gain insight into the difference in costs incurred
The implementation of advance care planning should benefit the care of hemato-oncology patients aged 18 years and older during the palliative phase of their illness The research focuses on
Oncology patients who have been treated in one or more hospitals from the oncology-network CONCORD after their death quantitative research
Oncology patients treated with palliative intent in one or more hospitals from this network interviews
Healthcare providers and implementation staff in the relevant hospitals and from the service area interviews Goal The aim of this project is to implement advance care planning in hemato-oncology patients treated in one of the hospitals within the oncology-network CONCORD so that personal preferences and treatment agreements lead to an appropriate treatment plan This is examined through the process of implementation and assurance of advance care planning in oncological care
MAIN QUESTION How is implementation and assurance of the online module advance care planning in daily care for hemato-oncological patients within the oncology-network CONCORD achieved so that early integration of advance care planning in oncological care takes place and patient preferences are discussed Method
Qualitative research
Description of the initial situation and the context within each institution but also of general practitioners and patients using the NASSS Framework Interviews with project leader project coordinators in each hospital healthcare providers from 1st 2nd and 3rd lines patients and relatives at the start and end of the project 3-5 in each target group per hospital taking into account the greatest possible degree of diversity in age gender and background At the end of the project the interviews are repeated to gather information about the experiences and lessons learned and the experiences with facilitating and hindering factors Each interview is transcribed and analyzed using NVivio or Atlasti analysis programs for qualitative data
Quantitative research
EHR-research based on anonymized data using a dashboard A dashboard is being built in each hospital to analyze data from hemato-oncological patients who have been treated in the relevant hospital and have died The dashboard contains demographic and medical data the use of the proactive care module and medical consumption in the last three months of their lives
In each of the participating hospitals the hemato-oncological patients who died in the last 3 months of 2022 2023 2024 and 2025 are selected and it will be examined to what extent the advance care plan has been completed and what kind of care the patients have received A Health economic analysis is carried out using the data from the dashboard On the one hand this involves the costs of implementing the advance care planning module used In addition the dashboard maps medical consumption in the last three months of life eg ICU admissions ER visits clinical admissions etc This is translated into the nationally determined costs for this This is done both before and after implementation has been mapped out among people who have died making it possible to gain insight into the difference in costs incurred
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 10200012110003 | OTHER_GRANT | ZonMw | None |